Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications

Abstract Current therapeutic approaches to depression fail for millions of patients due to lag in clinical response and non-adherence. Here we provide new support for the antidepressant effect of an anesthetic drug, ketamine, by Inverse-Frequency Analysis of eight million reports from the FDA Advers...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Isaac V. Cohen, Tigran Makunts, Rabia Atayee, Ruben Abagyan
Format: article
Langue:EN
Publié: Nature Portfolio 2017
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/29cfb95bdea44b70a57ebcd61bd9f670
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires